Edgewise Therapeutics, Inc. (EWTX) NASDAQ

29.31

-0.2(-0.68%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap2.47B
Enterprise Value2.43B
P/E Ratio-19.66
PEG Ratio10.16
Price/Sales Ratio0
Price/Book Ratio5.53
Enterprise/Revenue0
Enterprise/EBITDA-17.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.31

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-156.54M
Net Income-133.81M
Diluted EPS-1.45

Balance Sheet

Total Cash563.34M
Total Cash/Share5.34
Total Debt4.18M
Total Debt/Equity0.01
Current Ratio26.51
Book Value Per Share5.3

Price History

52-Week Change8.27
52-Week High31.29
52-Week Low10.6
Moving Average 50 Days26.11
Moving Average 200 Days18.22

Statistics

Average Volume1.38M
Shares Outstanding105.87M
% Held by Institutions32.91

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A